Genesis Genetics has named Tony Gordon as lab director of UK operations and vice president of US operations. In his role as vice president, Gordon will oversee scientific development, sales and marketing, and provide consultations on cytogenetics to US labs. He will also be instrumental in expanding reproductive health services throughout the organization by developing a global laboratory group to explore new technologies and diagnostic tests.

Prior to his role at Genesis Genetics, Gordon worked at BlueGnome in the UK where he, in part with Genesis Genetics, led the development of 24sure-PGS (Preimplantation Genetic Screening), which has been shown to increase pregnancy rates and reduce miscarriages. He also contributed to the development and global uptake of the CytoChip, a postnatal cytogenetic mental retardation/development delay microarray test.